$0.88+0.05 (+5.58%)
QTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA.
QTREX Quantum Ltd. in the Technology sector is trading at $0.88 with a market capitalization of $55M. Wall Street consensus targets $5.00 (1 analysts), implying a +468.2% move over the next 12 months. The stock is currently near its 52-week low of $0.28, remaining 6.4% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q4 2025 | Q4 2024 |
|---|---|---|
| Total Revenue | β | β |
| Gross Profit | β | β |
| Operating Income | β | β |
| Net Income | β | β |
QTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in I...

Qtrex Quantum Ltd (NASDAQ:QTEX) shares dropped 16% in premarket trading on Thursday after the company unveiled a $10 million registered direct offering involving more than 11 million ordinary shares. The Israel-based company has entered into a definitive securities purchase agreement with institutional investors covering the sale of 11,111,111 ordinary shares.

QTREX has demonstrated a patent-pending process that converts sections of 3D-printed insulation directly into conductive graphene-like carbon, with cryogenic validation and a commercial launch of its DF INSU300 material now among the next milestones. Key Investor TakeawaysQTREX (NASDAQ:QTEX) achieved direct conversion of 3D-printed dielectric material into electrically conductive, graphene-like carbon without adding separate conductive materials.
QTREX Quantum (NasdaqCM:QTEX) moved back into focus after filing two shelf registrations totaling about US$12.6 million in ordinary shares, including an ESOP related component. This development raises fresh questions about future dilution and capital flexibility. See our latest analysis for QTREX Quantum. The share price of QTREX Quantum has been under pressure in the short term. The 1 day, 7 day and 30 day share price returns have all declined sharply, even though the 90 day share price...
QTREX Quantum Ltd. (NASDAQ:QTEX) is one of the best performing tech stocks to buy according to analysts. On June 18, QTREX Quantum achieved a significant milestone by successfully producing a cryogenic chip carrier using its proprietary Additively Manufactured Electronics/AME process. Designed in collaboration with a major US technology firm, this single-build architecture integrates signal transport [β¦]
In late May 2026, QTREX Quantum Ltd. (formerly Inspira Technologies Oxy B.H.N. Ltd.) announced a US$10,000,000 private placement of 6,666,667 ordinary shares with a new institutional investor, alongside its name and Nasdaq ticker change to QTEX. This combination of fresh capital, corporate rebranding, and prior commercial traction for its ART100 extracorporeal blood circulation systems with NYU Langone highlights a company repositioning its identity and funding base. With a recent 7-day gain...